Concepedia

Nadine C. Salisch

NC

Statistics

Publications

8

Citations

285

H-Index

8

Active since

2008

Affiliations

Janssen (Netherlands)(Current)

Harvard University

Ragon Institute of MGH, MIT and Harvard

Janssen (Belgium)

Beth Israel Deaconess Medical Center

Nadine C. Salisch is an author at Janssen (Netherlands) specializing in infectious diseases, immunology, and molecular virology.

ORCID

Publications per year

2008–2022

8

Publications

8

A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine

Nadine C. Salisch, Kathryn E. Stephenson, Kristi L. Williams et al. · Annals of Internal Medicine · 2021 · 80 citations

, , +17

Inhibitory TCR Coreceptor PD-1 Is a Sensitive Indicator of Low-Level Replication of SIV and HIV-1

Nadine C. Salisch, Daniel E. Kaufmann, Amany Awad et al. · The Journal of Immunology · 2009 · 46 citations · Full text

, , +17

Characterization of CD8<sup>+</sup> T Cell Differentiation following SIVΔnef Vaccination by Transcription Factor Expression Profiling

James M. Billingsley, Premeela A. Rajakumar, Michelle Connole et al. · Insecta mundi · 2015 · 43 citations · Full text

, , +17

Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months

Arabella Stuart, Miia Virta, Kristi L. Williams et al. · The Journal of Infectious Diseases · 2022 · 37 citations · Full text

, , +17

Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations

Nadine C. Salisch, Ana Izquierdo Gil, Dominika N. Czapska-Casey et al. · npj Vaccines · 2019 · 34 citations · Full text

, , +17

1–5 of 8